Université Côte d'Azur, Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale, Institut de Pharmacologie Moléculaire et Cellulaire, Labex ICST, Valbonne, France.
Nat Rev Nephrol. 2019 Jul;15(7):412-422. doi: 10.1038/s41581-019-0143-6.
Mutations in the polycystins PC1 or PC2 cause autosomal dominant polycystic kidney disease (ADPKD), which is characterized by the formation of fluid-filled renal cysts that disrupt renal architecture and function, ultimately leading to kidney failure in the majority of patients. Although the genetic basis of ADPKD is now well established, the physiological function of polycystins remains obscure and a matter of intense debate. The structural determination of both the homomeric PC2 and heteromeric PC1-PC2 complexes, as well as the electrophysiological characterization of PC2 in the primary cilium of renal epithelial cells, provided new valuable insights into the mechanisms of ADPKD pathogenesis. Current findings indicate that PC2 can function independently of PC1 in the primary cilium of renal collecting duct epithelial cells to form a channel that is mainly permeant to monovalent cations and is activated by both membrane depolarization and an increase in intraciliary calcium. In addition, PC2 functions as a calcium-activated calcium release channel at the endoplasmic reticulum membrane. Structural studies indicate that the heteromeric PC1-PC2 complex comprises one PC1 and three PC2 channel subunits. Surprisingly, several positively charged residues from PC1 occlude the ionic pore of the PC1-PC2 complex, suggesting that pathogenic polycystin mutations might cause ADPKD independently of an effect on channel permeation. Emerging reports of novel structural and functional findings on polycystins will continue to elucidate the molecular basis of ADPKD.
多囊蛋白 1(PC1)或 PC2 的突变会导致常染色体显性多囊肾病(ADPKD),其特征是形成充满液体的肾囊肿,破坏肾脏结构和功能,最终导致大多数患者肾衰竭。尽管 ADPKD 的遗传基础现已得到充分确立,但多囊蛋白的生理功能仍不清楚,这是一个激烈争论的问题。同源 PC2 和异源 PC1-PC2 复合物的结构测定,以及 PC2 在肾上皮细胞初级纤毛中的电生理特性的表征,为 ADPKD 发病机制的研究提供了新的有价值的见解。目前的研究结果表明,PC2 可以在肾集合管上皮细胞的初级纤毛中独立于 PC1 发挥作用,形成一种主要允许单价阳离子通过的通道,该通道可被膜去极化和纤毛内钙增加激活。此外,PC2 作为内质网膜上的钙激活钙释放通道发挥作用。结构研究表明,异源 PC1-PC2 复合物由一个 PC1 和三个 PC2 通道亚基组成。令人惊讶的是,PC1 中的几个正电荷残基阻塞了 PC1-PC2 复合物的离子通道,这表明致病的多囊蛋白突变可能独立于对通道通透性的影响而导致 ADPKD。关于多囊蛋白的新的结构和功能发现的报告将继续阐明 ADPKD 的分子基础。